《改善全球肾脏病预后组织2020年临床实践指南：慢性肾脏病患者的糖尿病管理》推荐的降血糖治疗方案解读

2022-02-10 上海交通大学医学院附属第九人民医院肾内科上海医药

改善全球肾脏病预后组织(Kidney Disease:Improving Global Outcomes, KDIGO)发布了《KDIGO 2020年临床实践指南:慢性肾脏病患者的糖尿病管理》。

中文标题：

发布机构：

上海交通大学医学院附属第九人民医院肾内科

发布日期：

2022-02-10

简要介绍：

改善全球肾脏病预后组织(Kidney Disease:Improving Global Outcomes, KDIGO)发布了《KDIGO 2020年临床实践指南:慢性肾脏病患者的糖尿病管理》。该指南总结了以往的临床循证医学证据,尤其是近年来新型降血糖药物治疗对糖尿病患者靶器官保护的高质量证据,从血糖水平控制、生活方式干预和降血糖药物的选择等方面给出了临床医师科学管理糖尿病合并慢性肾脏病患者的推荐或建议。

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=d43a51c00236e3e3, title=《改善全球肾脏病预后组织2020年临床实践指南：慢性肾脏病患者的糖尿病管理》推荐的降血糖治疗方案解读, enTitle=, guiderFrom=上海医药, authorId=0, author=, summary=改善全球肾脏病预后组织(Kidney Disease:Improving Global Outcomes, KDIGO)发布了《KDIGO 2020年临床实践指南:慢性肾脏病患者的糖尿病管理》。, cover=https://img.medsci.cn/2022226/1645887248531_5579292.jpg, journalId=0, articlesId=null, associationId=2473, associationName=上海交通大学医学院附属第九人民医院肾内科, associationIntro=上海交通大学医学院附属第九人民医院肾内科, copyright=0, guiderPublishedTime=Thu Feb 10 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #333333;">改善全球肾脏病预后组织(Kidney Disease:Improving Global Outcomes, KDIGO)发布了《KDIGO 2020年临床实践指南:慢性肾脏病患者的糖尿病管理》。该指南总结了以往的临床循证医学证据,尤其是近年来新型降血糖药物治疗对糖尿病患者靶器官保护的高质量证据,从血糖水平控制、生活方式干预和降血糖药物的选择等方面给出了临床医师科学管理糖尿病合并慢性肾脏病患者的推荐或建议。 </span></p>, tagList=[TagDto(tagId=2527, tagName=慢性肾脏病), TagDto(tagId=2959, tagName=降血糖治疗)], categoryList=[CategoryDto(categoryId=14, categoryName=肾内科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21091, categoryName=“福星”CKD-MBD学院, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=解读, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4780, appHits=363, showAppHits=0, pcHits=644, showPcHits=4417, likes=2, shares=50, comments=6, approvalStatus=1, publishedTime=Sun Feb 27 15:27:00 CST 2022, publishedTimeString=2022-02-10, pcVisible=1, appVisible=1, editorId=0, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=FUNNYMAN, createdTime=Sat Feb 26 22:54:45 CST 2022, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Thu Jan 04 19:38:21 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=_改善全球肾脏病预后组织2020_..._病管理_推荐的降血糖治疗方案解读.pdf)])

_改善全球肾脏病预后组织2020_..._病管理_推荐的降血糖治疗方案解读.pdf

下载请点击：

评论区 (6)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=1247777, encodeId=e4cd124e7776a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210623/4d9e84f1341b41429a0939b359f17d64/bd35e2cbeed44b8085044684d5f6d2c1.jpg, createdBy=ade75532394, createdName=再造人, createdTime=Wed Sep 07 22:03:57 CST 2022, time=2022-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210282, encodeId=4a1912102823d, content=努力学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=553f6549965, createdName=ms5000001391033554, createdTime=Mon Apr 11 13:26:21 CST 2022, time=2022-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202351, encodeId=8a8b120235136, content=非常希望下载下来学习，可惜积分不够, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4af71613401, createdName=annie5685, createdTime=Sun Mar 13 23:14:56 CST 2022, time=2022-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202112, encodeId=80dc120211237, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4af71613401, createdName=annie5685, createdTime=Sat Mar 12 22:35:57 CST 2022, time=2022-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200176, encodeId=6dfe12001e6b4, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d95b6536849, createdName=ms5000000217784034, createdTime=Mon Mar 07 10:14:11 CST 2022, time=2022-03-07, status=1, ipAttribution=)]
2022-09-07 再造人

学习

26 0
[GetPortalCommentsPageByObjectIdResponse(id=1247777, encodeId=e4cd124e7776a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210623/4d9e84f1341b41429a0939b359f17d64/bd35e2cbeed44b8085044684d5f6d2c1.jpg, createdBy=ade75532394, createdName=再造人, createdTime=Wed Sep 07 22:03:57 CST 2022, time=2022-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210282, encodeId=4a1912102823d, content=努力学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=553f6549965, createdName=ms5000001391033554, createdTime=Mon Apr 11 13:26:21 CST 2022, time=2022-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202351, encodeId=8a8b120235136, content=非常希望下载下来学习，可惜积分不够, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4af71613401, createdName=annie5685, createdTime=Sun Mar 13 23:14:56 CST 2022, time=2022-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202112, encodeId=80dc120211237, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4af71613401, createdName=annie5685, createdTime=Sat Mar 12 22:35:57 CST 2022, time=2022-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200176, encodeId=6dfe12001e6b4, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d95b6536849, createdName=ms5000000217784034, createdTime=Mon Mar 07 10:14:11 CST 2022, time=2022-03-07, status=1, ipAttribution=)]
2022-04-11 ms5000001391033554

努力学习中

40 0
[GetPortalCommentsPageByObjectIdResponse(id=1247777, encodeId=e4cd124e7776a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210623/4d9e84f1341b41429a0939b359f17d64/bd35e2cbeed44b8085044684d5f6d2c1.jpg, createdBy=ade75532394, createdName=再造人, createdTime=Wed Sep 07 22:03:57 CST 2022, time=2022-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210282, encodeId=4a1912102823d, content=努力学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=553f6549965, createdName=ms5000001391033554, createdTime=Mon Apr 11 13:26:21 CST 2022, time=2022-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202351, encodeId=8a8b120235136, content=非常希望下载下来学习，可惜积分不够, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4af71613401, createdName=annie5685, createdTime=Sun Mar 13 23:14:56 CST 2022, time=2022-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202112, encodeId=80dc120211237, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4af71613401, createdName=annie5685, createdTime=Sat Mar 12 22:35:57 CST 2022, time=2022-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200176, encodeId=6dfe12001e6b4, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d95b6536849, createdName=ms5000000217784034, createdTime=Mon Mar 07 10:14:11 CST 2022, time=2022-03-07, status=1, ipAttribution=)]
2022-03-13 annie5685

非常希望下载下来学习，可惜积分不够

44 0
[GetPortalCommentsPageByObjectIdResponse(id=1247777, encodeId=e4cd124e7776a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210623/4d9e84f1341b41429a0939b359f17d64/bd35e2cbeed44b8085044684d5f6d2c1.jpg, createdBy=ade75532394, createdName=再造人, createdTime=Wed Sep 07 22:03:57 CST 2022, time=2022-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210282, encodeId=4a1912102823d, content=努力学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=553f6549965, createdName=ms5000001391033554, createdTime=Mon Apr 11 13:26:21 CST 2022, time=2022-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202351, encodeId=8a8b120235136, content=非常希望下载下来学习，可惜积分不够, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4af71613401, createdName=annie5685, createdTime=Sun Mar 13 23:14:56 CST 2022, time=2022-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202112, encodeId=80dc120211237, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4af71613401, createdName=annie5685, createdTime=Sat Mar 12 22:35:57 CST 2022, time=2022-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200176, encodeId=6dfe12001e6b4, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d95b6536849, createdName=ms5000000217784034, createdTime=Mon Mar 07 10:14:11 CST 2022, time=2022-03-07, status=1, ipAttribution=)]
2022-03-12 annie5685

学习中

57 0
[GetPortalCommentsPageByObjectIdResponse(id=1247777, encodeId=e4cd124e7776a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210623/4d9e84f1341b41429a0939b359f17d64/bd35e2cbeed44b8085044684d5f6d2c1.jpg, createdBy=ade75532394, createdName=再造人, createdTime=Wed Sep 07 22:03:57 CST 2022, time=2022-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210282, encodeId=4a1912102823d, content=努力学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=553f6549965, createdName=ms5000001391033554, createdTime=Mon Apr 11 13:26:21 CST 2022, time=2022-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202351, encodeId=8a8b120235136, content=非常希望下载下来学习，可惜积分不够, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4af71613401, createdName=annie5685, createdTime=Sun Mar 13 23:14:56 CST 2022, time=2022-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202112, encodeId=80dc120211237, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4af71613401, createdName=annie5685, createdTime=Sat Mar 12 22:35:57 CST 2022, time=2022-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200176, encodeId=6dfe12001e6b4, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d95b6536849, createdName=ms5000000217784034, createdTime=Mon Mar 07 10:14:11 CST 2022, time=2022-03-07, status=1, ipAttribution=)]
2022-03-07 ms5000000217784034

学习

46 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

肾内科指南

《改善全球肾脏病预后组织2020年临床实践指南：慢性肾脏病患者的糖尿病管理》推荐的降血糖治疗方案解读

相关指南

科室

工具

服务